Benjamin Burnett
Stock Analyst at Wells Fargo
(3.12)
# 2,548
Out of 4,520 analysts
386
Total ratings
46.2%
Success rate
2.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Rated: Buy | $160 → $161 | $108.32 | +48.63% | 8 | Jul 16, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Hold | $323 | $314.41 | +2.73% | 6 | Jun 30, 2026 | |
| ALKS Alkermes | Rated: Buy | $44 → $65 | $52.72 | +23.29% | 11 | Jun 29, 2026 | |
| TECX Tectonic Therapeutic | Rated: Buy | $101 | $32.60 | +209.82% | 3 | Jun 12, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $255 | $230.00 | +10.87% | 7 | Jun 10, 2026 | |
| LQDA Liquidia | Maintained: Buy | $62 | $79.94 | -22.44% | 5 | Jun 4, 2026 | |
| MNKD MannKind | Maintained: Buy | $11 | $4.03 | +172.95% | 6 | Jun 2, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $69 | $68.26 | +1.08% | 10 | Jun 1, 2026 | |
| SVRA Savara | Rated: Buy | $9 | $5.52 | +63.04% | 5 | May 22, 2026 | |
| WVE Wave Life Sciences | Rated: Buy | $13 → $14 | $5.82 | +140.55% | 7 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $20 | $10.64 | +87.97% | 4 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $19.75 | -3.77% | 1 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $575 → $738 | $535.67 | +37.77% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $47 | $29.28 | +60.52% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $42.62 | +7.93% | 3 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 | $78.59 | +9.43% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $64 | $186.16 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $13 | $2.83 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.95 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $5.00 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $1.79 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $8.39 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $2.78 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $92 | $76.15 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $0.885 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $49 | $47.78 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $64 | $36.01 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.0006 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $7.87 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.9 → $3.6 | $0.065 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.7 → $3 | $68.26 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $37.31 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.000001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $27.53 | n/a | 2 | Feb 28, 2022 |
Insmed
Jul 16, 2026
Rated: Buy
Price Target: $160 → $161
Current: $108.32
Upside: +48.63%
Praxis Precision Medicines
Jun 30, 2026
Rated: Hold
Price Target: $323
Current: $314.41
Upside: +2.73%
Alkermes
Jun 29, 2026
Rated: Buy
Price Target: $44 → $65
Current: $52.72
Upside: +23.29%
Tectonic Therapeutic
Jun 12, 2026
Rated: Buy
Price Target: $101
Current: $32.60
Upside: +209.82%
Axsome Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: $255
Current: $230.00
Upside: +10.87%
Liquidia
Jun 4, 2026
Maintained: Buy
Price Target: $62
Current: $79.94
Upside: -22.44%
MannKind
Jun 2, 2026
Maintained: Buy
Price Target: $11
Current: $4.03
Upside: +172.95%
Xenon Pharmaceuticals
Jun 1, 2026
Maintained: Buy
Price Target: $69
Current: $68.26
Upside: +1.08%
Savara
May 22, 2026
Rated: Buy
Price Target: $9
Current: $5.52
Upside: +63.04%
Wave Life Sciences
May 20, 2026
Rated: Buy
Price Target: $13 → $14
Current: $5.82
Upside: +140.55%
May 15, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $10.64
Upside: +87.97%
May 14, 2026
Downgraded: Hold
Price Target: $19
Current: $19.75
Upside: -3.77%
May 7, 2026
Upgraded: Buy
Price Target: $575 → $738
Current: $535.67
Upside: +37.77%
May 6, 2026
Maintained: Buy
Price Target: $45 → $47
Current: $29.28
Upside: +60.52%
Apr 22, 2026
Maintained: Buy
Price Target: $46
Current: $42.62
Upside: +7.93%
Apr 13, 2026
Maintained: Buy
Price Target: $86
Current: $78.59
Upside: +9.43%
Apr 1, 2025
Maintained: Buy
Price Target: $78 → $64
Current: $186.16
Upside: n/a
Mar 31, 2025
Maintained: Buy
Price Target: $26 → $13
Current: $2.83
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $4.95
Upside: n/a
Mar 17, 2025
Maintained: Buy
Price Target: $18
Current: $5.00
Upside: n/a
Mar 17, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $1.79
Upside: n/a
Mar 11, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $8.39
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $2.78
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $94 → $92
Current: $76.15
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $80
Current: $0.885
Upside: n/a
Feb 13, 2025
Maintained: Hold
Price Target: $53 → $49
Current: $47.78
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $66 → $64
Current: $36.01
Upside: n/a
Apr 19, 2024
Maintained: Buy
Price Target: $10
Current: $0.0006
Upside: n/a
Aug 16, 2023
Maintained: Buy
Price Target: $42
Current: $7.87
Upside: n/a
Aug 10, 2023
Maintained: Hold
Price Target: $3.9 → $3.6
Current: $0.065
Upside: n/a
Mar 2, 2023
Maintained: Hold
Price Target: $4.7 → $3
Current: $68.26
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $37.31
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.000001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $27.53
Upside: n/a